Product correctly added to cart.

discount label
Aliudanexin
View 3D

Biosynth logo

Aliudanexin

CAS: 2241128-93-6

Ref. 3D-RPD12893

25mg
180.00 €
250mg
718.00 €
Estimated delivery in United States, on Monday 25 Nov 2024

Product Information

Name:
Aliudanexin
Description:

Aliudanexin is a peptide that binds to the extracellular domain of the human receptor for advanced glycation end products (RAGE) with high affinity and selectivity. Aliudanexin inhibits the activity of RAGE, which is implicated in inflammation, cell death, and insulin resistance. Aliudanexin blocks the interaction of RAGE with its ligands, including AGEs and S100 proteins. This inhibition prevents RAGE-mediated activation of ion channels and downstream signaling pathways. Thus, aliudanexin may be a novel therapeutic agent for diseases associated with AGEs.

Aliudanexin is a potent inhibitor of the human receptor for advanced glycation end products (RAGE). It competes with ligands such as advanced glycation end products (RAGE) and S100 proteins for binding to RAGE, blocking its interactions with these ligands and preventing their activation of ion channels and downstream signaling pathways. Aliudanex

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
409.6 g/mol
Formula:
C13H18Cl5N3O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-RPD12893 Aliudanexin

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".